What is Disease Memory in Psoriasis?
Dr. Gudjonsson highlights disease memory and how it can provide a potential treatment target.
Dr. Gudjonsson highlights disease memory and how it can provide a potential treatment target.
Dr. Blauvelt discusses results from his research study where high doses of a medication is provided to “knock out” disease
Dr. Smith reviews how biomarkers can be used to identify patients at risk for severe disease and those who would
Focus on Psoriasis – A Report from the 2021 Virtual EADV Congress Download PDF
Why We Need To Stratify in Treatment of Psoriasis Lars Iversen, MD, DMSC | Denmark 2021
The Psoriasis Pipeline: Upcoming New Systemic Drugs Andrew Blauvelt, MD, MBA | United States 2021
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |